InsidersTradesSigma
경보제약 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 경보제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 경보제약 has recorded 28 reports. Market capitalisation: €124.6bn. The latest transaction was reported on 19 March 2026 (Purchase). Among the most active insiders: 종근당홀딩스. All data is openly available.
28
Insider Decl.
0
Thresholds
€6,454
8 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,345 of 25,619 companies
28.1
score / 100
Value26
Quality30
FCF yld-28%
Earn yld0.1%
EV/EBITDA14.0x
ROE0.2%
Gross mgn39%
Net mgn0.1%
Debt/EBITDA7.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 March 2026
Declarations28 total
25 of 28 declarations